Find More Contacts for Connect Biopharmaceuticals
Protected Content
VP
VP Management
1 phone number found
View contacts for Connect Biopharmaceuticals to access new leads and connect with decision-makers.
View All Contacts

Details

Edit Details Section
  • Contact Email swlu@connectpharm.com
  • Phone Number 0512-53577866

Connect Biopharmaceuticals is a clinical-stage company that discovers and develops novel medicines for the treatment of autoimmune diseases and inflammation. They identify and advance our drug candidates through in-house discovery and in-licensing while leveraging qualified CROs for further development. The company successfully completed a phase I

clinical trial study on our leading program CBP-307, a novel and selective second-generation S1P1 (a G-protein coupled receptor -GPCR) modulator for the treatment of a range of autoimmune disorders, including multiple sclerosis, inflammatory bowel disease, and psoriasis.

Connect Biopharmaceuticals currently conducting two phases 2 clinical studies in patients with ulcerative colitis and Crohn's disease with their lead drug candidate CBP-307. It also concluding a phase 1 study of our second drug candidate CBP-201 in healthy subjects, with a phase 1b study in atopic dermatitis patients expected to commence in Q1, 2019.

Connect Biopharmaceuticals was founded in 2012 and is headquartered in Taichang, China.

Lists Featuring This Company

Edit Lists Featuring This Company Section
Asia Biotechnology Public Companies
657 Number of Organizations • $43.1B Total Funding Amount • 1,270 Number of Investors
Biotechnology Companies With More Than $10M in Revenue
4,792 Number of Organizations • $590.2B Total Funding Amount • 12,163 Number of Investors
China Companies With Less Than $500M in Revenue (Top 10K)
9,674 Number of Organizations • $280.6B Total Funding Amount • 13,771 Number of Investors
Asia Companies With Less Than $1B in Revenue (Top 10K)
9,935 Number of Organizations • $886B Total Funding Amount • 66,742 Number of Investors

Frequently Asked Questions

Edit Frequently Asked Questions Section
Where is Connect Biopharmaceuticals's headquarters? Connect Biopharmaceuticals is located in Taicang, Hebei, China.Who invested in Connect Biopharmaceuticals? Connect Biopharmaceuticals has 11 investors including Qiming Venture Partners and HBM Healthcare Investments AG.How much funding has Connect Biopharmaceuticals raised to date? Connect Biopharmaceuticals has raised
$195M
.When was the last funding round for Connect Biopharmaceuticals? Connect Biopharmaceuticals closed its last funding round on Aug 24, 2020 from a Series C round.Who are Connect Biopharmaceuticals's competitors? Alternatives and possible competitors to Connect Biopharmaceuticals may include Affimed, Semma Therapeutics, and Pandion Therapeutics.